Heritability and genome-wide association study of benign prostatic hyperplasia (BPH) in the eMERGE network

Benign Prostatic Hyperplasia (BPH)Lower Urinary Tract SymptomsOveractive Bladder

Prostatic stromal inflammation is associated with bladder outlet obstruction in patients with benign prostatic hyperplasia

Prostate.

Inamura S, Ito H, Shinagawa T, Tsutsumiuchi M, Taga M, Kobayashi M, Yokoyama O

doi: 10.1002/pros.23518.

Benign Prostatic Hyperplasia (BPH)

Transperineal laser ablation for percutaneous treatment of benign prostatic hyperplasia: a feasibility study. Results at 6 and 12 months from a retrospective multi-centric study

Prostate Cancer Prostatic Dis.

Pacella CM, Patelli G, Iapicca G, Manenti G, Perretta T, Ryan CP, Esposito R, Mauri G

doi: 10.1038/s41391-019-0196-4.

Benign Prostatic Hyperplasia (BPH)Lower Urinary Tract Symptoms

The UK ROPE Study: efficacy and safety of prostate artery embolisation for benign prostatic hyperplasia. An observational study and propensity matched comparison with transurethral resection of the prostate

BJU Int.

Ray AF, Powell J, Speakman MJ, Longford NT, DasGupta R, Bryant T, Modi S, Dyer J, Harris M, Carolan-Rees G, Hacking N

doi: 10.1111/bju.14249.

Benign Prostatic Hyperplasia (BPH)

Allopurinol and risk of benign prostatic hyperplasia in a Finnish population-based cohort

Prostate Cancer Prostatic Dis

Kukko V, Kaipia A, Talala K, Taari K, Tammela TLJ, Auvinen A, Murtola TJ

doi: 10.1038/s41391-017-0031-8.

Benign Prostatic Hyperplasia (BPH)

Association of Prostatic Volume and Carotid Intima-Media Thickness in Patients with Benign Prostatic Hyperplasia

Urology.

Erbay AR, Ede H, Zengin K, Erkoc MF, Tanık S, Albayrak S, Yetkin E

doi: 10.1016/j.urology.2017.11.051.

Benign Prostatic Hyperplasia (BPH)

Smoking habits and benign prostatic hyperplasia: A systematic review and meta-analysis of observational studies

Medicine (Baltimore).

Xu H, Fu S, Chen Y, Chen Q, Gu M, Wang Z.

doi: 10.1097/

Benign Prostatic Hyperplasia (BPH)Erectile and Sexual Functions and DysfunctionsLower Urinary Tract Symptoms

Prostate Artery Embolization for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: Results from a Prospective FDA-Approved Investigational Device Exemption Study

Urology.

Salem R, Hairston J, Hohlastos E, Riaz A, Kallini J, Gabr A, Ali R, Jenkins K, Karp J, Desai K, Thornburg B, Casalino D, Miller F, Hofer M, Hamoui N, Mouli S

doi: 10.1016/j.urology.

Benign Prostatic Hyperplasia (BPH)Lower Urinary Tract Symptoms

The Relationship between the Clinical Progression of Benign Prostatic Hyperplasia and Metabolic Syndrome: A Prospective Study

Urol Int.

Fu Y, Zhou Z, Yang B, Zhang K, He L, Zhang X.

doi: 10.1159/000448484

Benign Prostatic Hyperplasia (BPH)Lower Urinary Tract SymptomsOveractive Bladder

Nerve growth factor levels are associated with overactive bladder symptoms and long-term treatment outcome after transurethral resection of the prostate in patients with benign prostate hyperplasia

J Urol.

Hu H, Zhang W, Liu X, Wang H, Fang Z, Liang C, Wang T, Xu K

doi: 10.1016/j.juro.2018.03.130.

Related content

Prostatic stromal inflammation is associated with bladder outlet obstruction in patients with benign prostatic hyperplasia

Transperineal laser ablation for percutaneous treatment of benign prostatic hyperplasia: a feasibility study. Results at 6 and 12 months from a retrospective multi-centric study

The UK ROPE Study: efficacy and safety of prostate artery embolisation for benign prostatic hyperplasia. An observational study and propensity matched comparison with transurethral resection of the prostate

Allopurinol and risk of benign prostatic hyperplasia in a Finnish population-based cohort

Association of Prostatic Volume and Carotid Intima-Media Thickness in Patients with Benign Prostatic Hyperplasia

Smoking habits and benign prostatic hyperplasia: A systematic review and meta-analysis of observational studies

Prostate Artery Embolization for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: Results from a Prospective FDA-Approved Investigational Device Exemption Study

The Relationship between the Clinical Progression of Benign Prostatic Hyperplasia and Metabolic Syndrome: A Prospective Study

Nerve growth factor levels are associated with overactive bladder symptoms and long-term treatment outcome after transurethral resection of the prostate in patients with benign prostate hyperplasia